RedHill Biopharma Statistics
Total Valuation
RDHL has a market cap or net worth of $5.32 million. The enterprise value is $2.42 million.
Important Dates
The last earnings date was Monday, April 27, 2026, before market open.
| Earnings Date | Apr 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RDHL has 5.11 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 5.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +39.93% |
| Owned by Insiders (%) | 1.26% |
| Owned by Institutions (%) | 3.60% |
| Float | 4.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.59 |
| Forward PS | n/a |
| PB Ratio | 1.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.25.
| Current Ratio | 0.34 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.79% |
| Return on Invested Capital (ROIC) | -977.87% |
| Return on Capital Employed (ROCE) | -129.15% |
| Weighted Average Cost of Capital (WACC) | 44.05% |
| Revenue Per Employee | $8,171 |
| Profits Per Employee | -$12,257 |
| Employee Count | 35 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.68% in the last 52 weeks. The beta is 4.92, so RDHL's price volatility has been higher than the market average.
| Beta (5Y) | 4.92 |
| 52-Week Price Change | -57.68% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 68.89 |
| Average Volume (20 Days) | 43,687 |
Short Selling Information
The latest short interest is 7,163, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 7,163 |
| Short Previous Month | 19,603 |
| Short % of Shares Out | 0.15% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.34 |
Income Statement
In the last 12 months, RDHL had revenue of $286,000 and -$429,000 in losses.
| Revenue | 286,000 |
| Gross Profit | 286,000 |
| Operating Income | -7.91M |
| Pretax Income | -8.08M |
| Net Income | -429,000 |
| EBITDA | -7.50M |
| EBIT | -7.91M |
| Earnings Per Share (EPS) | n/a |
Full Income StatementBalance Sheet
The company has $3.97 million in cash and $1.07 million in debt, giving a net cash position of $2.90 million or $0.57 per share.
| Cash & Cash Equivalents | 3.97M |
| Total Debt | 1.07M |
| Net Cash | 2.90M |
| Net Cash Per Share | $0.57 |
| Equity (Book Value) | 4.27M |
| Book Value Per Share | n/a |
| Working Capital | -12.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.19 million and capital expenditures -$5,000, giving a free cash flow of -$7.20 million.
| Operating Cash Flow | -7.19M |
| Capital Expenditures | -5,000 |
| Depreciation & Amortization | 409,000 |
| Net Borrowing | -447,000 |
| Free Cash Flow | -7.20M |
| FCF Per Share | -$1.41 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -2,765.38% and -150.00%.
| Gross Margin | 100.00% |
| Operating Margin | -2,765.38% |
| Pretax Margin | -2,825.17% |
| Profit Margin | -150.00% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |